Psychiatry Specialty: Addiction Treatment Tools, Training, and Resources
1 in 4 people with serious mental illness also have a substance use disorder.ⁱ Those with SUD may also struggle with mental health: researchers estimate that up to 30% of opioid overdoses may be suicide attempts.ⁱⁱ In another study, people who misused prescription opioids were 40-60% more likely to have thoughts of suicide as compared to those who did not report opioid misuse.ⁱⁱⁱ
The ASAM National Practice Guideline 2020 focused update is intended to inform and empower clinicians, health system administrators, criminal justice system administrators, and policymakers who are interested in implementing evidence-based practices to improve outcomes for individuals with OUD. This is especially critical in the context of the ongoing COVID-19 emergency, which threatens to curtail patient access to evidence-based treatment.
This TIP reviews three Food and Drug Administration-approved medications for opioid use disorder treatment—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support people in recovery.
NIDAMED’s mission is to develop science-based resources for health professionals and those in training about screening, addressing, and treating addiction.
Live This Week Training
The ASAM Alcohol Withdrawal Management Webinar Series - Pharmacotherapy
The webinar follows the ASAM Alcohol Withdrawal Management Fundamentals webinar, which intends to aid clinicians in their clinical decision making and management of patients experiencing alcohol withdrawal syndrome, as written in The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management.
Appropriate pharmacotherapy for alcohol withdrawal is a balance of alleviating symptoms and normalizing signs of AWS while preventing the adverse effects associated with the medications being administered. This webinar will provide an overview of the recommendations around the appropriate use of pharmacotherapy for patients with AWS.
Date: Tuesday, October 20, 2020
Time: 12:00 pm ET / 11:00 am CT/ 9:00 am PT
On-Demand Training Opportunities:
The ASAM Treatment of Opioid Use Disorder Course provides required education essential for providers to identify, assess, diagnose, and manage patients with opioid use disorder (OUD). The course covers all medications and treatments for OUD. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training.
ⁱ Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2020.
ⁱⁱ Oquendo MA, Volkow ND. Suicide: A Silent Contributor to Opioid-Overdose Deaths. N Engl J Med. 2018;378(17):1567-1569.